| Literature DB >> 18561871 |
Bernadeta Szewczyk1, Paul R Albert, Ariel M Burns, Margaret Czesak, James C Overholser, George J Jurjus, Herbert Y Meltzer, Lisa C Konick, Lesa Dieter, Nicole Herbst, Warren May, Grazyna Rajkowska, Craig A Stockmeier, Mark C Austin.
Abstract
A variety of studies have documented alterations in 5-HT1A receptor binding sites in the brain of subjects with major depressive disorder (MDD). The recently identified transcription factor, nuclear deformed epidermal autoregulatory factor (NUDR/Deaf-1) has been shown to function as a transcriptional modulator of the human 5-HT1A receptor gene. The present study was undertaken to document the regional and cellular localization of NUDR in the human prefrontal cortex and to examine the levels of NUDR and 5-HT1A receptor protein in prefrontal cortex of female and male depressed and control subjects. NUDR immunoreactivity was present in neurons and glia across cortical layers and was co-localized with 5-HT1A receptor immunoreactive neurons. NUDR immunoreactivity as measured by Western blot was significantly decreased in the prefrontal cortex of female depressed subjects (42%, p=0.02) and unchanged in male depressed subjects relative to gender-matched control subjects. Similarly, 5-HT1A receptor protein level was significantly reduced in the prefrontal cortex of female depressed subjects (46%, p=0.03) and unchanged in male depressed subjects compared to gender-matched control subjects. Reduced protein expression of NUDR in the prefrontal cortex of female subjects with MDD may reflect a functional alteration in this transcription factor, which may contribute to the decrease in 5-HT1A receptors observed in the same female subjects with MDD. In addition, the gender-specific alterations in cortical NUDR and 5-HT1A receptor proteins could represent an underlying biological mechanism associated with the higher incidence of depression in women.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18561871 PMCID: PMC2645471 DOI: 10.1017/S1461145708009012
Source DB: PubMed Journal: Int J Neuropsychopharmacol ISSN: 1461-1457 Impact factor: 5.176